+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Generative AI in Personalized Medicine Market 2025-2029

  • PDF Icon

    Report

  • 234 Pages
  • August 2025
  • Region: Global
  • TechNavio
  • ID: 6119813
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The generative AI in personalized medicine market is forecasted to grow by USD 8.45 billion during 2024-2029, accelerating at a CAGR of 41.1% during the forecast period. The report on the generative AI in personalized medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by accelerated drug discovery and development cycles as a primary catalyst, intensifying strategic collaborations and influx of capital as a key market accelerator, and expansion of accessible multimodal data and computational power as a foundational enabler.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The generative AI in personalized medicine market is segmented as below:

By Application

  • Drug discovery
  • Disease diagnosis
  • Genomic analysis

By End-user

  • Pharmaceutical
  • Academic institutes
  • Hospitals
  • Diagnostic centers

By Therapeutic Area

  • Oncology
  • Neurology
  • Cardiology
  • Rare diseases
  • Infectious diseases

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa
This study identifies the rise of biological foundation models and AI factories as one of the prime reasons driving the generative AI in personalized medicine market growth during the next few years. Also, emergence of multimodal AI for a holistic view of disease and paradigm shift toward in-silico clinical trials and digital twins will lead to sizable demand in the market.

The report on the generative AI in personalized medicine market covers the following areas:

  • Generative AI In Personalized Medicine Market sizing
  • Generative AI In Personalized Medicine Market forecast
  • Generative AI In Personalized Medicine Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generative AI in personalized medicine market vendors that include Ardigen S.A., BenevolentAI, Freenome Holdings Inc., Google LLC, Insilico Medicine, International Business Machines Corp., Mediwhale Inc., Microsoft Corp., NVIDIA Corp., Owkin Inc., PathAI Inc., Qure.ai Technologies Pvt. Ltd., Shenzhen Jingtai Technology Co. Ltd., Syntekabio Inc., Tempus Labs Inc., and TurinTech AI Inc. Also, the generative AI in personalized medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
5.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Drug discovery - Market size and forecast 2024-2029
Chart on Drug discovery - Market size and forecast 2024-2029 ($ million)
Data Table on Drug discovery - Market size and forecast 2024-2029 ($ million)
Chart on Drug discovery - Year-over-year growth 2024-2029 (%)
Data Table on Drug discovery - Year-over-year growth 2024-2029 (%)
6.4 Disease diagnosis - Market size and forecast 2024-2029
Chart on Disease diagnosis - Market size and forecast 2024-2029 ($ million)
Data Table on Disease diagnosis - Market size and forecast 2024-2029 ($ million)
Chart on Disease diagnosis - Year-over-year growth 2024-2029 (%)
Data Table on Disease diagnosis - Year-over-year growth 2024-2029 (%)
6.5 Genomic analysis - Market size and forecast 2024-2029
Chart on Genomic analysis - Market size and forecast 2024-2029 ($ million)
Data Table on Genomic analysis - Market size and forecast 2024-2029 ($ million)
Chart on Genomic analysis - Year-over-year growth 2024-2029 (%)
Data Table on Genomic analysis - Year-over-year growth 2024-2029 (%)
6.6 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
7.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
7.3 Pharmaceutical - Market size and forecast 2024-2029
Chart on Pharmaceutical - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmaceutical - Market size and forecast 2024-2029 ($ million)
Chart on Pharmaceutical - Year-over-year growth 2024-2029 (%)
Data Table on Pharmaceutical - Year-over-year growth 2024-2029 (%)
7.4 Academic institutes - Market size and forecast 2024-2029
Chart on Academic institutes - Market size and forecast 2024-2029 ($ million)
Data Table on Academic institutes - Market size and forecast 2024-2029 ($ million)
Chart on Academic institutes - Year-over-year growth 2024-2029 (%)
Data Table on Academic institutes - Year-over-year growth 2024-2029 (%)
7.5 Hospitals - Market size and forecast 2024-2029
Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
7.6 Diagnostic centers - Market size and forecast 2024-2029
Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)
7.7 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
8 Market Segmentation by Therapeutic Area
8.1 Market segments
Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)
8.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
8.3 Oncology - Market size and forecast 2024-2029
Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)
8.4 Neurology - Market size and forecast 2024-2029
Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Chart on Neurology - Year-over-year growth 2024-2029 (%)
Data Table on Neurology - Year-over-year growth 2024-2029 (%)
8.5 Cardiology - Market size and forecast 2024-2029
Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
8.6 Rare diseases - Market size and forecast 2024-2029
Chart on Rare diseases - Market size and forecast 2024-2029 ($ million)
Data Table on Rare diseases - Market size and forecast 2024-2029 ($ million)
Chart on Rare diseases - Year-over-year growth 2024-2029 (%)
Data Table on Rare diseases - Year-over-year growth 2024-2029 (%)
8.7 Infectious diseases - Market size and forecast 2024-2029
Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
9 Customer Landscape
9.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Geographic Landscape
10.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
10.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
10.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
10.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
10.5 APAC - Market size and forecast 2024-2029
Chart on APAC - Market size and forecast 2024-2029 ($ million)
Data Table on APAC - Market size and forecast 2024-2029 ($ million)
Chart on APAC - Year-over-year growth 2024-2029 (%)
Data Table on APAC - Year-over-year growth 2024-2029 (%)
10.6 South America - Market size and forecast 2024-2029
Chart on South America - Market size and forecast 2024-2029 ($ million)
Data Table on South America - Market size and forecast 2024-2029 ($ million)
Chart on South America - Year-over-year growth 2024-2029 (%)
Data Table on South America - Year-over-year growth 2024-2029 (%)
10.7 Middle East and Africa - Market size and forecast 2024-2029
Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
10.8 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
10.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
10.10 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
10.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
10.12 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
10.13 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
10.14 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
10.15 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
10.16 Spain - Market size and forecast 2024-2029
Chart on Spain - Market size and forecast 2024-2029 ($ million)
Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Chart on Spain - Year-over-year growth 2024-2029 (%)
Data Table on Spain - Year-over-year growth 2024-2029 (%)
10.17 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
10.18 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
11 Drivers, Challenges, and Opportunity/Restraints
11.1 Market drivers
11.2 Market challenges
11.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
11.4 Market opportunities/restraints
12 Competitive Landscape
12.1 Overview
12.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
12.3 Landscape disruption
Overview on factors of disruption
12.4 Industry risks
Impact of key risks on business
13 Competitive Analysis
13.1 Companies profiled
Companies covered
13.2 Company ranking index
Company ranking index
13.3 Market positioning of companies
Matrix on companies position and classification
13.4 Ardigen S.A.
Ardigen S.A. - Overview
Ardigen S.A. - Product / Service
Ardigen S.A. - Key offerings
SWOT
13.5 BenevolentAI
BenevolentAI - Overview
BenevolentAI - Product / Service
BenevolentAI - Key offerings
SWOT
13.6 Freenome Holdings Inc.
Freenome Holdings Inc. - Overview
Freenome Holdings Inc. - Product / Service
Freenome Holdings Inc. - Key offerings
SWOT
13.7 Google LLC
Google LLC - Overview
Google LLC - Product / Service
Google LLC - Key offerings
SWOT
13.8 Insilico Medicine
Insilico Medicine - Overview
Insilico Medicine - Product / Service
Insilico Medicine - Key offerings
SWOT
13.9 International Business Machines Corp.
International Business Machines Corp. - Overview
International Business Machines Corp. - Business segments
International Business Machines Corp. - Key news
International Business Machines Corp. - Key offerings
International Business Machines Corp. - Segment focus
SWOT
13.10 Microsoft Corp.
Microsoft Corp. - Overview
Microsoft Corp. - Business segments
Microsoft Corp. - Key news
Microsoft Corp. - Key offerings
Microsoft Corp. - Segment focus
SWOT
13.11 NVIDIA Corp.
NVIDIA Corp. - Overview
NVIDIA Corp. - Business segments
NVIDIA Corp. - Key news
NVIDIA Corp. - Key offerings
NVIDIA Corp. - Segment focus
SWOT
13.12 Owkin Inc.
Owkin Inc. - Overview
Owkin Inc. - Product / Service
Owkin Inc. - Key offerings
SWOT
13.13 PathAI Inc.
PathAI Inc. - Overview
PathAI Inc. - Product / Service
PathAI Inc. - Key offerings
SWOT
13.14 Qure.ai Technologies Pvt. Ltd.
Qure.ai Technologies Pvt. Ltd. - Overview
Qure.ai Technologies Pvt. Ltd. - Product / Service
Qure.ai Technologies Pvt. Ltd. - Key offerings
SWOT
13.15 Shenzhen Jingtai Technology Co. Ltd.
Shenzhen Jingtai Technology Co. Ltd. - Overview
Shenzhen Jingtai Technology Co. Ltd. - Product / Service
Shenzhen Jingtai Technology Co. Ltd. - Key offerings
SWOT
13.16 Syntekabio Inc.
Syntekabio Inc. - Overview
Syntekabio Inc. - Product / Service
Syntekabio Inc. - Key offerings
SWOT
13.17 Tempus Labs Inc.
Tempus Labs Inc. - Overview
Tempus Labs Inc. - Product / Service
Tempus Labs Inc. - Key offerings
SWOT
13.18 TurinTech AI Inc.
TurinTech AI Inc. - Overview
TurinTech AI Inc. - Product / Service
TurinTech AI Inc. - Key offerings
SWOT
14 Appendix
14.1 Scope of the report
14.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
14.3 Currency conversion rates for US$
Currency conversion rates for US$
14.4 Research methodology
Research methodology
14.5 Data procurement
Information sources
14.6 Data validation
Data validation
14.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
14.8 Data synthesis
Data synthesis
14.9 360 degree market analysis
360 degree market analysis
14.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Five forces analysis - Comparison between 2024 and 2029
Exhibits 26: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 28: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 29: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 30: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 31: Chart on Market condition - Five forces 2024 and 2029
Exhibits 32: Chart on Application - Market share 2024-2029 (%)
Exhibits 33: Data Table on Application - Market share 2024-2029 (%)
Exhibits 34: Chart on Comparison by Application
Exhibits 35: Data Table on Comparison by Application
Exhibits 36: Chart on Drug discovery - Market size and forecast 2024-2029 ($ million)
Exhibits 37: Data Table on Drug discovery - Market size and forecast 2024-2029 ($ million)
Exhibits 38: Chart on Drug discovery - Year-over-year growth 2024-2029 (%)
Exhibits 39: Data Table on Drug discovery - Year-over-year growth 2024-2029 (%)
Exhibits 40: Chart on Disease diagnosis - Market size and forecast 2024-2029 ($ million)
Exhibits 41: Data Table on Disease diagnosis - Market size and forecast 2024-2029 ($ million)
Exhibits 42: Chart on Disease diagnosis - Year-over-year growth 2024-2029 (%)
Exhibits 43: Data Table on Disease diagnosis - Year-over-year growth 2024-2029 (%)
Exhibits 44: Chart on Genomic analysis - Market size and forecast 2024-2029 ($ million)
Exhibits 45: Data Table on Genomic analysis - Market size and forecast 2024-2029 ($ million)
Exhibits 46: Chart on Genomic analysis - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on Genomic analysis - Year-over-year growth 2024-2029 (%)
Exhibits 48: Market opportunity by Application ($ million)
Exhibits 49: Data Table on Market opportunity by Application ($ million)
Exhibits 50: Chart on End-user - Market share 2024-2029 (%)
Exhibits 51: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 52: Chart on Comparison by End-user
Exhibits 53: Data Table on Comparison by End-user
Exhibits 54: Chart on Pharmaceutical - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Data Table on Pharmaceutical - Market size and forecast 2024-2029 ($ million)
Exhibits 56: Chart on Pharmaceutical - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Pharmaceutical - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Data Table on Academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits 60: Chart on Academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits 62: Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 63: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
Exhibits 64: Chart on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 65: Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
Exhibits 66: Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
Exhibits 67: Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ million)
Exhibits 68: Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
Exhibits 69: Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)
Exhibits 70: Market opportunity by End-user ($ million)
Exhibits 71: Data Table on Market opportunity by End-user ($ million)
Exhibits 72: Chart on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 73: Data Table on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 74: Chart on Comparison by Therapeutic Area
Exhibits 75: Data Table on Comparison by Therapeutic Area
Exhibits 76: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 77: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 78: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 80: Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits 81: Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits 82: Chart on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 83: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 84: Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits 85: Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits 86: Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits 87: Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits 88: Chart on Rare diseases - Market size and forecast 2024-2029 ($ million)
Exhibits 89: Data Table on Rare diseases - Market size and forecast 2024-2029 ($ million)
Exhibits 90: Chart on Rare diseases - Year-over-year growth 2024-2029 (%)
Exhibits 91: Data Table on Rare diseases - Year-over-year growth 2024-2029 (%)
Exhibits 92: Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits 93: Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits 95: Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits 96: Market opportunity by Therapeutic Area ($ million)
Exhibits 97: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibits 98: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 99: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 100: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 101: Chart on Geographic comparison
Exhibits 102: Data Table on Geographic comparison
Exhibits 103: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 104: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 105: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 106: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 107: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 108: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 109: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 110: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 111: Chart on APAC - Market size and forecast 2024-2029 ($ million)
Exhibits 112: Data Table on APAC - Market size and forecast 2024-2029 ($ million)
Exhibits 113: Chart on APAC - Year-over-year growth 2024-2029 (%)
Exhibits 114: Data Table on APAC - Year-over-year growth 2024-2029 (%)
Exhibits 115: Chart on South America - Market size and forecast 2024-2029 ($ million)
Exhibits 116: Data Table on South America - Market size and forecast 2024-2029 ($ million)
Exhibits 117: Chart on South America - Year-over-year growth 2024-2029 (%)
Exhibits 118: Data Table on South America - Year-over-year growth 2024-2029 (%)
Exhibits 119: Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Exhibits 120: Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
Exhibits 121: Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Exhibits 122: Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
Exhibits 123: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 124: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 125: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 126: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 127: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 128: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 129: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 130: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 131: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 132: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 133: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 134: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 135: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 136: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 137: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 138: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 139: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 140: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 141: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 142: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 143: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 144: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 145: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 146: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 147: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 148: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 149: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 150: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 151: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 152: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 153: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 154: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 155: Chart on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 156: Data Table on Spain - Market size and forecast 2024-2029 ($ million)
Exhibits 157: Chart on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 158: Data Table on Spain - Year-over-year growth 2024-2029 (%)
Exhibits 159: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 160: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 161: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 162: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 163: Market opportunity By Geographical Landscape ($ million)
Exhibits 164: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 165: Impact of drivers and challenges in 2024 and 2029
Exhibits 166: Overview on criticality of inputs and factors of differentiation
Exhibits 167: Overview on factors of disruption
Exhibits 168: Impact of key risks on business
Exhibits 169: Companies covered
Exhibits 170: Company ranking index
Exhibits 171: Matrix on companies position and classification
Exhibits 172: Ardigen S.A. - Overview
Exhibits 173: Ardigen S.A. - Product / Service
Exhibits 174: Ardigen S.A. - Key offerings
Exhibits 175: SWOT
Exhibits 176: BenevolentAI - Overview
Exhibits 177: BenevolentAI - Product / Service
Exhibits 178: BenevolentAI - Key offerings
Exhibits 179: SWOT
Exhibits 180: Freenome Holdings Inc. - Overview
Exhibits 181: Freenome Holdings Inc. - Product / Service
Exhibits 182: Freenome Holdings Inc. - Key offerings
Exhibits 183: SWOT
Exhibits 184: Google LLC - Overview
Exhibits 185: Google LLC - Product / Service
Exhibits 186: Google LLC - Key offerings
Exhibits 187: SWOT
Exhibits 188: Insilico Medicine - Overview
Exhibits 189: Insilico Medicine - Product / Service
Exhibits 190: Insilico Medicine - Key offerings
Exhibits 191: SWOT
Exhibits 192: International Business Machines Corp. - Overview
Exhibits 193: International Business Machines Corp. - Business segments
Exhibits 194: International Business Machines Corp. - Key news
Exhibits 195: International Business Machines Corp. - Key offerings
Exhibits 196: International Business Machines Corp. - Segment focus
Exhibits 197: SWOT
Exhibits 198: Microsoft Corp. - Overview
Exhibits 199: Microsoft Corp. - Business segments
Exhibits 200: Microsoft Corp. - Key news
Exhibits 201: Microsoft Corp. - Key offerings
Exhibits 202: Microsoft Corp. - Segment focus
Exhibits 203: SWOT
Exhibits 204: NVIDIA Corp. - Overview
Exhibits 205: NVIDIA Corp. - Business segments
Exhibits 206: NVIDIA Corp. - Key news
Exhibits 207: NVIDIA Corp. - Key offerings
Exhibits 208: NVIDIA Corp. - Segment focus
Exhibits 209: SWOT
Exhibits 210: Owkin Inc. - Overview
Exhibits 211: Owkin Inc. - Product / Service
Exhibits 212: Owkin Inc. - Key offerings
Exhibits 213: SWOT
Exhibits 214: PathAI Inc. - Overview
Exhibits 215: PathAI Inc. - Product / Service
Exhibits 216: PathAI Inc. - Key offerings
Exhibits 217: SWOT
Exhibits 218: Qure.ai Technologies Pvt. Ltd. - Overview
Exhibits 219: Qure.ai Technologies Pvt. Ltd. - Product / Service
Exhibits 220: Qure.ai Technologies Pvt. Ltd. - Key offerings
Exhibits 221: SWOT
Exhibits 222: Shenzhen Jingtai Technology Co. Ltd. - Overview
Exhibits 223: Shenzhen Jingtai Technology Co. Ltd. - Product / Service
Exhibits 224: Shenzhen Jingtai Technology Co. Ltd. - Key offerings
Exhibits 225: SWOT
Exhibits 226: Syntekabio Inc. - Overview
Exhibits 227: Syntekabio Inc. - Product / Service
Exhibits 228: Syntekabio Inc. - Key offerings
Exhibits 229: SWOT
Exhibits 230: Tempus Labs Inc. - Overview
Exhibits 231: Tempus Labs Inc. - Product / Service
Exhibits 232: Tempus Labs Inc. - Key offerings
Exhibits 233: SWOT
Exhibits 234: TurinTech AI Inc. - Overview
Exhibits 235: TurinTech AI Inc. - Product / Service
Exhibits 236: TurinTech AI Inc. - Key offerings
Exhibits 237: SWOT
Exhibits 238: Inclusions checklist
Exhibits 239: Exclusions checklist
Exhibits 240: Currency conversion rates for US$
Exhibits 241: Research methodology
Exhibits 242: Information sources
Exhibits 243: Data validation
Exhibits 244: Validation techniques employed for market sizing
Exhibits 245: Data synthesis
Exhibits 246: 360 degree market analysis
Exhibits 247: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global generative ai in personalized medicine market: Ardigen S.A., BenevolentAI, Freenome Holdings Inc., Google LLC, Insilico Medicine, International Business Machines Corp., Mediwhale Inc., Microsoft Corp., NVIDIA Corp., Owkin Inc., PathAI Inc., Qure.ai Technologies Pvt. Ltd., Shenzhen Jingtai Technology Co. Ltd., Syntekabio Inc., Tempus Labs Inc., and TurinTech AI Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rise of biological foundation models and ai factories."

According to the report, one of the major drivers for this market is the accelerated drug discovery and development cycles as a primary catalyst.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ardigen S.A.
  • BenevolentAI
  • Freenome Holdings Inc.
  • Google LLC
  • Insilico Medicine
  • International Business Machines Corp.
  • Mediwhale Inc.
  • Microsoft Corp.
  • NVIDIA Corp.
  • Owkin Inc.
  • PathAI Inc.
  • Qure.ai Technologies Pvt. Ltd.
  • Shenzhen Jingtai Technology Co. Ltd.
  • Syntekabio Inc.
  • Tempus Labs Inc.
  • TurinTech AI Inc.